Conversely, OR2B11, OR52K1, and OR3A2 were up-regulated in GBM tissues and non-neoplastic cells, implying their roles in modulating the TME to promote tumorigenesis (Figure 2C and Table S1). The gene discussed is OR2B11; the disease is glioblastoma.